These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7828457)

  • 1. Once-a-day administration of amikacin in neonates: assessment of nephrotoxicity and ototoxicity.
    Langhendries JP; Battisti O; Bertrand JM; François A; Darimont J; Ibrahim S; Tulkens PM; Bernard A; Buchet JP; Scalais E
    Dev Pharmacol Ther; 1993; 20(3-4):220-30. PubMed ID: 7828457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary phospholipids excretion in neonates treated with amikacin.
    Ibrahim S; Langhendries JP; Bernard A; Tulkens PM
    Int J Clin Pharmacol Res; 1994; 14(5-6):149-56. PubMed ID: 7672871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit.
    Langhendries JP; Battisti O; Bertrand JM; François A; Kalenga M; Darimont J; Scalais E; Wallemacq P
    Biol Neonate; 1998 Nov; 74(5):351-62. PubMed ID: 9742264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the renal and auditory function of neonates treated with amikacin.
    Parini R; Rusconi F; Cavanna G; Vigliani E; Cornacchia L; Assael BM
    Dev Pharmacol Ther; 1982; 5(1-2):33-46. PubMed ID: 7151635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease.
    Ibrahim S; Derde MP; Kaufman L; Clerckx-Braun F; Jacqmin P; Brulein V; Donnez J; Tulkens PM
    Ren Fail; 1990; 12(3):199-203. PubMed ID: 2287773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.
    Rao SC; Ahmed M; Hagan R
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005091. PubMed ID: 16437518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin-induced ototoxicity and nephrotoxicity vary with circadian time of treatment and entail separate mechanisms.
    Blunston MA; Yonovitz A; Woodahl EL; Smolensky MH
    Chronobiol Int; 2015; 32(9):1223-32. PubMed ID: 26506922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of enzymuria as an indicator of amikacin-induced renal damage in guinea pigs.
    Suzuki CA; Thomas BH; Mueller R
    Toxicol Lett; 1992 Aug; 62(1):101-14. PubMed ID: 1509502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
    Goren MP; Baker DK; Shenep JL
    Pediatr Infect Dis J; 1989 May; 8(5):278-82. PubMed ID: 2657616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once versus twice daily amikacin in neonates: prospective study on toxicity.
    Kotze A; Bartel PR; Sommers DK
    J Paediatr Child Health; 1999 Jun; 35(3):283-6. PubMed ID: 10404451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
    Sweileh WM
    Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin.
    Tulkens PM
    J Antimicrob Chemother; 1991 May; 27 Suppl C():49-61. PubMed ID: 1856146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymuria determination in children treated with aminoglycosides drugs.
    Mohammadi-Karakani A; Asgharzadeh-Haghighi S; Ghazi-Khansari M; Seyed-Ebrahimi A; Ghasemi A; Jabari E
    Hum Exp Toxicol; 2008 Dec; 27(12):879-82. PubMed ID: 19273542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between amikacin blood concentration and ototoxicity in low birth weight infants.
    Endo A; Nemoto A; Hanawa K; Maebayashi Y; Hasebe Y; Kobayashi M; Naito A; Kobayashi Y; Yamamoto S; Isobe K
    J Infect Chemother; 2019 Jan; 25(1):17-21. PubMed ID: 30539740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of two amikacin dosing regimens in paediatric surgical patients.
    Forsyth NB; Botha JH; Hadley GP
    Ann Trop Paediatr; 1997 Sep; 17(3):253-61. PubMed ID: 9425382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside-related nephrotoxicity in the premature newborn.
    Rajchgot P; Prober CG; Soldin S; Perlman M; Good F; Harding E; Klein J; MacLeod S
    Clin Pharmacol Ther; 1984 Mar; 35(3):394-401. PubMed ID: 6365403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.